SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Thase Michael E)
 

Search: WFRF:(Thase Michael E) > (2015-2019) > The Risk of Treatme...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Viktorin, AlexanderKarolinska Institutet (author)

The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • Arlington, USA :American Psychiatric Association Publishing,2017
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-54653
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-54653URI
  • https://doi.org/10.1176/appi.ajp.2016.16040467DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:135466138URI
  • https://gup.ub.gu.se/publication/247675URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies:Swedish Research Council through the Swedish Initiative for research on Microdata in the Social and Medical Sciences (SIMSAM)  340-2013-5867Swedish Medical Research Council  K2014-62X-14647-12-51  K2010-61P-21568-01-4NIMH  1R01MH102221Agency for Healthcare Research and Quality  Alkermes  AssureRx  Avanir  Forest Pharmaceuticals  Janssen  Otsuka  Shire  American Psychiatric Foundation  Guilford Publications  Herald House  Oxford University Press Affiliations: No connection is given between individuals and the declared affiliations. The affiliations are: Department of Medical Epidemiology and Biostatistics and the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; the Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York; the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Psychological and Brain Sciences, Indiana University, Bloomington; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm; the Department of Medical Sciences, Örebro University, Örebro, Sweden; and the Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
  • Objective: The authors sought to determine the risk of treatment-emergent mania associated with methylphenidate, used in monotherapy or with a concomitant mood-stabilizing medication, in patients with bipolar disorder.Method: Using linked Swedish national registries, the authors identified 2,307 adults with bipolar disorder who initiated therapy with methylphenidate between 2006 and 2014. The cohort was divided into two groups: those with and those without concomitant mood-stabilizing treatment. To adjust for individual-specific confounders, including disorder severity, genetic makeup, and early environmental factors, Cox regression analyses were used, conditioning on individual to compare the rate of mania (defined as hospitalization for mania or a new dispensation of stabilizing medication) 0-3 months and 3-6 months after medication start following nontreated periods.Results: Patients on methylphenidate monotherapy displayed an increased rate of manic episodes within 3 months of medication initiation (hazard ratio=6.7, 95% CI=2.0-22.4), with similar results for the subsequent 3 months. By contrast, for patients taking mood stabilizers, the risk of mania was lower after starting methylphenidate (hazard ratio=0.6, 95% CI=0.4-0.9). Comparable results were observed when only hospitalizations for mania were counted.Conclusions: No evidence was found for a positive association between methylphenidate and treatment-emergent mania among patients with bipolar disorder who were concomitantly receiving a mood-stabilizing medication. This is clinically important given that up to 20% of people with bipolar disorder suffer from comorbid ADHD. Given the markedly increased hazard ratio of mania following methylphenidate initiation in bipolar patients not taking mood stabilizers, careful assessment to rule out bipolar disorder is indicated before initiating monotherapy with psychostimulants.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Rydén, Eleonore (author)
  • Thase, Michael E. (author)
  • Chang, ZhengKarolinska Institutet (author)
  • Lundholm, CeciliaKarolinska Institutet (author)
  • D'Onofrio, Brian M.Karolinska Institutet (author)
  • Almqvist, CatarinaKarolinska Institutet (author)
  • Magnusson, Patrik K. E.Karolinska Institutet (author)
  • Lichtenstein, PaulKarolinska Institutet (author)
  • Larsson, Henrik,1975-Karolinska Institutet,Örebro universitet,Institutionen för medicinska vetenskaper(Swepub:oru)hiln (author)
  • Landén, Mikael,1966Gothenburg University,Göteborgs universitet,Karolinska Institutet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology(Swepub:gu)xlandt (author)
  • Karolinska InstitutetInstitutionen för medicinska vetenskaper (creator_code:org_t)

Related titles

  • In:American Journal of PsychiatryArlington, USA : American Psychiatric Association Publishing174:4, s. 341-3480002-953X1535-7228

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view